Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
23.72
+2.52 (11.89%)
Aug 12, 2025, 11:54 AM - Market open
Sumo Logic Market Cap
Liquidia has a market cap or net worth of $2.03 billion as of August 12, 2025. Its market cap has increased by 131.55% in one year.
Market Cap
2.03B
Enterprise Value
1.79B
1-Year Change
131.55%
Ranking
Category
Stock Price
$23.72
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $2.03B, an increase of 1,108.58%. That is a compound annual growth rate of 42.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 1.81B | 82.08% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | 127.84M | 60.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |